Cero Therapeutics Holdings Inc (CERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2002 | 03-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -1 | -2,380 | -1,760 | -21,650 |
| Depreciation Amortization | N/A | N/A | 350 | 190 | 1,620 |
| Accounts payable and accrued liabilities | N/A | 1 | N/A | N/A | N/A |
| Other Working Capital | N/A | 1 | -1,310 | 340 | 13,330 |
| Other Operating Activity | 0 | -1 | -220 | 290 | 6,570 |
| Operating Cash Flow | $N/A | $N/A | $-3,560 | $-940 | $-130 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -160 | -70 | -990 |
| Other Investing Activity | 0 | 0 | -10 | 0 | 140 |
| Investing Cash Flow | $N/A | $N/A | $-170 | $-70 | $-850 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 3 | 0 | 40 |
| Financing Cash Flow | $N/A | $N/A | $3 | $0 | $40 |
| Beginning Cash Position | N/A | N/A | 4,140 | 4,140 | 5,080 |
| End Cash Position | N/A | N/A | 400 | 3,120 | 4,140 |
| Net Cash Flow | $N/A | $N/A | $-3,740 | $-1,020 | $-940 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | -3,560 | -940 | -130 |
| Free Cash Flow | 0 | 0 | -3,560 | -940 | -130 |